These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 38123231)

  • 1. Clinical-radiological-pathological correlation in pulmonary arterial hypertension.
    Condliffe R; Durrington C; Hameed A; Lewis RA; Venkateswaran R; Gopalan D; Dorfmüller P
    Eur Respir Rev; 2023 Dec; 32(170):. PubMed ID: 38123231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary arterial hypertension.
    Montani D; Günther S; Dorfmüller P; Perros F; Girerd B; Garcia G; Jaïs X; Savale L; Artaud-Macari E; Price LC; Humbert M; Simonneau G; Sitbon O
    Orphanet J Rare Dis; 2013 Jul; 8():97. PubMed ID: 23829793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schistosomiasis-associated pulmonary arterial hypertension: a systematic review.
    Knafl D; Gerges C; King CH; Humbert M; Bustinduy AL
    Eur Respir Rev; 2020 Mar; 29(155):. PubMed ID: 32024722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary artery compliance in different forms of pulmonary hypertension.
    McCormick A; Krishnan A; Badesch D; Benza RL; Bull TM; De Marco T; Feldman J; Hemnes AR; Hirsch R; Horn E; Kennedy J; Mathai SC; McConnell W; Pugliese SC; Sager JS; Shlobin OA; Simon MA; Lammi MR
    Heart; 2023 Jun; 109(14):1098-1105. PubMed ID: 36787969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
    Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
    [No Abstract]   [Full Text] [Related]  

  • 6. Aetiological distribution of pulmonary hypertension and the value of transthoracic echocardiography screening in the respiratory department: A retrospective analysis from China.
    Hong C; Chen R; Hu L; Liu H; Lu J; Zhuang C; Guo W; Wu X; Lin J; Sun X; Tang H; Wang Z; Zhang N; Zheng Z
    Clin Respir J; 2023 Jun; 17(6):536-547. PubMed ID: 37141914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and Treatment of Pulmonary Arterial Hypertension: A Review.
    Ruopp NF; Cockrill BA
    JAMA; 2022 Apr; 327(14):1379-1391. PubMed ID: 35412560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Classification, diagnosis and treatment status of pulmonary hypertension from 2012 to 2019: a single center study in Yunnan province].
    Feng XL; Lu YB; Yang D; Xue Q; Zhang JL; Lin CR; Gan P; Zhang WH; Guang XF; Dai HL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Nov; 51(11):1188-1193. PubMed ID: 37963755
    [No Abstract]   [Full Text] [Related]  

  • 9. Pulmonary arterial hypertension: guidelines and unmet clinical needs.
    Giuggioli D; Bruni C; Cacciapaglia F; Dardi F; De Cata A; Del Papa N; Iannone F; Lunardi C; Maglione W; Molinaro F; Palazzini M; Spinella A; Tinazzi E; Matucci Cerinic M
    Reumatismo; 2021 Jan; 72(4):228-246. PubMed ID: 33677950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recommendations for the diagnosis and treatment of connective tissue disease associated pulmonary arterial hypertension in China].
    Zhang X; Zhao JL; Ding F; Yang J; Wang J; Zeng XF; Zhao Y
    Zhonghua Nei Ke Za Zhi; 2022 Nov; 61(11):1206-1216. PubMed ID: 36323561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemodynamic effects of PAH-targeted therapies in pulmonary hypertension due to lung disease: A systematic review and meta-analysis.
    Farmakis IT; Vazakidis P; Doundoulakis I; Arvanitaki A; Zafeiropoulos S; Boutou A; Karvounis H; Giannakoulas G
    Pulm Pharmacol Ther; 2021 Jun; 68():102036. PubMed ID: 33979684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial cells in the pathogenesis of pulmonary arterial hypertension.
    Evans CE; Cober ND; Dai Z; Stewart DJ; Zhao YY
    Eur Respir J; 2021 Sep; 58(3):. PubMed ID: 33509961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical phenotypes, hemodynamic characteristics and prognosis of Chinese patients with systemic sclerosis-associated precapillary pulmonary hypertension: a retrospective study.
    Yuan YP; Yuan P; Su YL; Jiang R; Zhang R; He J; Qiu HL; Luo CJ; Liu JM; Gong SG; Wang L; Zhao QH
    Clin Rheumatol; 2022 Jun; 41(6):1675-1686. PubMed ID: 35099674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-energy CT lung perfusion characteristics in pulmonary arterial hypertension (PAH) and pulmonary veno-occlusive disease and/or pulmonary capillary hemangiomatosis (PVOD/PCH): preliminary experience in 63 patients.
    Lefebvre B; Kyheng M; Giordano J; Lamblin N; de Groote P; Fertin M; Delobelle M; Perez T; Faivre JB; Remy J; Duhamel A; Remy-Jardin M
    Eur Radiol; 2022 Jul; 32(7):4574-4586. PubMed ID: 35286410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Counseling and Testing in Pulmonary Arterial Hypertension.
    Elliott CG
    Methodist Debakey Cardiovasc J; 2021; 17(2):101-105. PubMed ID: 34326929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating Riociguat in the Treatment of Pulmonary Arterial Hypertension: A Real-World Perspective.
    Mihalek AD; Scott CD; Mazimba S
    Vasc Health Risk Manag; 2022; 18():823-832. PubMed ID: 36299800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of pulmonary arterial hypertension during pregnancy.
    Krishnathasan K; Constantine A; Rafiq I; Barradas Pires A; Douglas H; Price LC; Dimopoulos K
    Expert Rev Respir Med; 2023 May; 17(5):413-423. PubMed ID: 37159412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on pediatric pulmonary arterial hypertension.
    Ivy D; Frank BS
    Curr Opin Cardiol; 2021 Jan; 36(1):67-79. PubMed ID: 33136663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New progress in diagnosis and treatment of pulmonary arterial hypertension.
    Zhang ZQ; Zhu SK; Wang M; Wang XA; Tong XH; Wan JQ; Ding JW
    J Cardiothorac Surg; 2022 Aug; 17(1):216. PubMed ID: 36038916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regnase-1 Prevents Pulmonary Arterial Hypertension Through mRNA Degradation of Interleukin-6 and Platelet-Derived Growth Factor in Alveolar Macrophages.
    Yaku A; Inagaki T; Asano R; Okazawa M; Mori H; Sato A; Hia F; Masaki T; Manabe Y; Ishibashi T; Vandenbon A; Nakatsuka Y; Akaki K; Yoshinaga M; Uehata T; Mino T; Morita S; Ishibashi-Ueda H; Morinobu A; Tsujimura T; Ogo T; Nakaoka Y; Takeuchi O
    Circulation; 2022 Sep; 146(13):1006-1022. PubMed ID: 35997026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.